Precigen, Inc. SEC filings PGEN
Precigen, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jan 26, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Mar 5, 2026 | — |
| CORRESP | Letter to the SEC | Feb 23, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2026 | — |
| CORRESP | Letter to the SEC | Jan 29, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| EFFECT | Filing | Sep 19, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2025 | — |
| EFFECT | Filing | Jan 17, 2024 | — |
| CORRESP | Letter to the SEC | Jan 12, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2024 | — |
| D | Filing | Dec 17, 2020 | — |
| EFFECT | Filing | Oct 9, 2020 | — |
| CORRESP | Letter to the SEC | Oct 7, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2020 | — |
| EFFECT | Filing | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jun 30, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2020 | — |
| D | Filing | Feb 11, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2019 | — |
| CORRESP | Letter to the SEC | Aug 23, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2019 | — |
| CT ORDER | Filing | Mar 11, 2019 | — |
| CT ORDER | Filing | Nov 19, 2018 | — |
| 25 | Form 25 | Sep 24, 2018 | — |
| CERT | Filing | Sep 24, 2018 | — |
| 8-A12B | Filing | Sep 24, 2018 | — |
| NT 10-Q | Filing | Aug 10, 2018 | Jun 30, 2018 |
| 305B2 | Filing | Jun 29, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2018 | — |
| CORRESP | Letter to the SEC | Apr 19, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2018 | — |
| EFFECT | Filing | May 12, 2017 | — |
| CORRESP | Letter to the SEC | May 11, 2017 | — |
| UPLOAD | Letter from the SEC | May 8, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| UPLOAD | Letter from the SEC | May 4, 2017 | — |
| CT ORDER | Filing | Apr 17, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2017 | — |
| 425 | 8-k | Jan 24, 2017 | — |
| D | Filing | Mar 9, 2016 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Germantown, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1356090
- Former names
- INTREXON CORP (until Jan 22, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.